Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial
Titel:
Pegfilgrastim administration after 24 or 72 or 96 h to allow dose-dense anthracycline- and taxane-based chemotherapy in breast cancer patients: a single-center experience within the GIM2 randomized phase III trial
Auteur:
Lambertini, Matteo Bruzzi, Paolo Poggio, Francesca Pastorino, Simona Gardin, Giovanni Clavarezza, Matteo Bighin, Claudia Pronzato, Paolo Mastro, Lucia Del